RSV is reportedly affecting adults, with outcomes in older adults potentially being worse than those associated with influenza. Studies suggest that symptoms of RSV in older adults can persist, and there is interest in vaccination as a preventative measure, with some vaccines showing effectiveness when coadministered with covid-19 vaccines. The severity of RSV in adults is a concern, with potential complications including pneumonia, prompting efforts to inform healthcare providers and vaccinate at-risk adults.